📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lundbeck

1.1 - Company Overview

Lundbeck Logo

Lundbeck

Headquarter: Denmark
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceuticals for psychiatric and neurological disorders, engaged globally in the research, development, production, marketing, and sale of these products.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lundbeck

Satsuma Pharmaceuticals Logo

Satsuma Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical development for migraine, advancing STS101, a drug-device combination featuring a proprietary dry-powder formulation of dihydroergotamine (DHE) for the acute treatment of migraine, self-administered via a pre-filled, single-use nasal delivery device.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Satsuma Pharmaceuticals company profile →
BetterLife Pharma Logo

BetterLife Pharma

HQ: Canada Website
  • Description: Provider of nutraceuticals and pharmaceuticals, engaged in production and commercialization, with product candidates including BETR-001, a non-hallucinogenic LSD derivative for psychiatric and neurological disorders; BETR-002, a hydrohonokiol derivative for benzodiazepine dependency, anxiety, and neurodegenerative disorders (oral capsule); and a viral infection candidate, including COVID-19, via subsidiary MedMelior.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BetterLife Pharma company profile →
Q'Apel Medical Logo

Q'Apel Medical

HQ: United States Website
  • Description: Provider of neurovascular access and stroke intervention devices, including the Walrus Balloon Catheter System for mechanical thrombectomy with a large inner diameter and high trackability; the Hippo Advanced Aspiration System for rapid clot removal with visible clot engagement and flexible navigation; and the Armadillo Neurovascular Access System with dual-mode radial and femoral adaptability, trackability, and support for complex anatomy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Q'Apel Medical company profile →
Auspex Pharma Logo

Auspex Pharma

HQ: United States Website
  • Description: Provider of development and commercialization of novel medicines for orphan diseases, with product candidates addressing unmet needs in hyperkinetic movement disorders such as chorea associated with Huntington's disease; also a deuteration company developing therapeutics for depressive disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Auspex Pharma company profile →
Cognito Therapeutics Logo

Cognito Therapeutics

HQ: United States Website
  • Description: Provider of non-invasive gamma wave therapy that evokes brain gamma activity via visual and auditory stimulation to slow cognitive and functional decline in Alzheimer’s; personalized intensity guided by EEG. Runs the HOPE pivotal study and Phase 2 OVERTURE showing preserved cognition, daily function, and brain volume. Holds FDA Breakthrough Device Designation; developing disease-modifying treatments for CNS illnesses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cognito Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lundbeck

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lundbeck

2.2 - Growth funds investing in similar companies to Lundbeck

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lundbeck

4.2 - Public trading comparable groups for Lundbeck

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lundbeck

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lundbeck

What does Lundbeck do?

Lundbeck is a provider of pharmaceuticals for psychiatric and neurological disorders, engaged globally in the research, development, production, marketing, and sale of these products.

Who are Lundbeck's competitors?

Lundbeck's competitors and similar companies include Satsuma Pharmaceuticals, BetterLife Pharma, Q'Apel Medical, Auspex Pharma, and Cognito Therapeutics.

Where is Lundbeck headquartered?

Lundbeck is headquartered in Denmark.

How many employees does Lundbeck have?

Lundbeck has 1,000 employees 🔒.

When was Lundbeck founded?

Lundbeck was founded in 2010 🔒.

What sector and industry vertical is Lundbeck in?

Lundbeck is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lundbeck

Who are the top strategic acquirers in Lundbeck's sector and industry

Top strategic M&A buyers and acquirers in Lundbeck's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lundbeck?

Top strategic M&A buyers groups and sectors for Lundbeck include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lundbeck's sector and industry vertical

Which are the top PE firms investing in Lundbeck's sector and industry vertical?

Top PE firms investing in Lundbeck's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lundbeck's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lundbeck's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lundbeck's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lundbeck include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lundbeck's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lundbeck?

The key public trading comparables and valuation benchmarks for Lundbeck include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lundbeck for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lundbeck with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lundbeck's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lundbeck with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lundbeck's' sector and industry vertical?

Access recent funding rounds and capital raises in Lundbeck's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lundbeck